These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6376067)

  • 21. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
    Niklson IA; Reimitz PE; Sennef C
    Psychopharmacol Bull; 1997; 33(1):41-51. PubMed ID: 9133750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Introduction: defining remission in patients treated with antidepressants.
    Thase ME
    J Clin Psychiatry; 1999; 60 Suppl 22():3-6. PubMed ID: 10634348
    [No Abstract]   [Full Text] [Related]  

  • 23. [Pharmacologic treatment of bulimia].
    Corcos M; Flament M; Atger F; Jeammet P
    Encephale; 1996; 22(2):133-42. PubMed ID: 8706623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Moclobemide and sertraline in the treatment of depressive disorders: a comparative study.
    Orsel Donbak S; Turkçapar MH; Ozturk Kiliç EZ; Demirergi N; Akdemir A; Sirin A; Ozbay MH
    Acta Psychiatr Belg; 1995; 95(3):139-51. PubMed ID: 8525856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized, double-blind, placebo-controlled trial of augmentation with an extended release formulation of methylphenidate in outpatients with treatment-resistant depression.
    Patkar AA; Masand PS; Pae CU; Peindl K; Hooper-Wood C; Mannelli P; Ciccone P
    J Clin Psychopharmacol; 2006 Dec; 26(6):653-6. PubMed ID: 17110825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comments on "Clinical trials of antidepressants: time to shift to a new model" by Dr Katz.
    Rickels K; Robinson DS
    J Clin Psychopharmacol; 2009 Apr; 29(2):197-8; author reply 198-9. PubMed ID: 19512995
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety and efficacy of bupropion in elderly patients: preliminary observations.
    Kane JM; Cole K; Sarantakos S; Howard A; Borenstein M
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):134-6. PubMed ID: 6406442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of bupropion and amitriptyline in depressed outpatients.
    Mendels J; Amin MM; Chouinard G; Cooper AJ; Miles JE; Remick RA; Saxena B; Secunda SK; Singh AN
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):118-20. PubMed ID: 6406439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the safety and efficacy of bupropion in depression.
    Halaris AE; Stern WC; Van Wyck Fleet J; Reno RM
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):101-3. PubMed ID: 6406435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Review of placebo-controlled trials with bupropion.
    Zung WW
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):104-14. PubMed ID: 6406436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of clinical and psychological methods in estimating antidepressants efficacy in treatment of depression (preliminary report)].
    Puzyński S; Koszewska I; Habrat E; Fornal S; Bzinkowska D; Gradzka D; Kalinowski A; Swiecicki Ł; Torbiński J
    Psychiatr Pol; 2002; 36(2):225-38. PubMed ID: 12043041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Randomized double-blind comparative study of the efficacy and tolerance of medifoxamine and imipramine in depressed patients].
    Olié JP; Galinowski A; Lehert P; Lemonnier F; Lôo H
    Encephale; 1993; 19(4):333-40. PubMed ID: 8275921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial clinical evaluation of a new nontricyclic antidepressant: clovoxamine.
    Freeman HL; Wakelin JS; Calanca A; Hole G
    Adv Biochem Psychopharmacol; 1982; 32():69-75. PubMed ID: 7046368
    [No Abstract]   [Full Text] [Related]  

  • 34. Nefazodone: aspects of efficacy.
    Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
    J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorder.
    Bakish D; Ravindran A; Hooper C; Lapierre Y
    Psychopharmacol Bull; 1994; 30(1):53-9. PubMed ID: 7972630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methodology to measure onset of action.
    Thase ME
    J Clin Psychiatry; 2001; 62 Suppl 15():18-21. PubMed ID: 11444762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new antidepressant agent: amitriptyline-N-oxide.
    Borromei A
    Adv Biochem Psychopharmacol; 1982; 32():43-7. PubMed ID: 7046367
    [No Abstract]   [Full Text] [Related]  

  • 38. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contribution of dissociative symptoms to antisocial behavior in a sample of high-school students].
    Chabrol H; Saint-Martin C; Sejourné N; Moyano O
    Encephale; 2009 Feb; 35(1):52-6. PubMed ID: 19250994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.